Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Tatva Chintan Pharma Chem's
Operating Income
for the
three
months ended in Jun. 2026 was ₹217 Mil. Tatva Chintan Pharma Chem's Interest Expense for the
three
months ended in Jun. 2026 was ₹-21 Mil.
Tatva Chintan Pharma Chem's interest coverage for the quarter that ended in Jun. 2026 was 10.44.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Tatva Chintan Pharma Chem's Interest Coverage or its related term are showing as below:
BOM:543321'
s Interest Coverage Range Over the Past 10 Years
Min: 5.08 Med: 12.01 Max: 23.17
Current: 15.42
BOM:543321's Interest Coverage is ranked better than 57.66% of 1233
companies
in the Chemicals industry
Industry Median: 10.26
vs BOM:543321: 15.42
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Tatva Chintan Pharma Chem Interest Coverage Related Terms
Tatva Chintan Pharma Chem Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:543321 vs LIN, SHW, ECL: Interest Coverage Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem Interest Coverage vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (BOM:543321) has a Interest Coverage of 10.44 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tatva Chintan Pharma Chem and its competitors. This is 13% below median its historical median of 12.01. Over the past decade, Tatva Chintan Pharma Chem's Interest Coverage has ranged from 5.08 to 23.17. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #522 out of 1233 companies in the Chemicals industry, placing it in the top 42.3%.
Is Tatva Chintan Pharma Chem's Interest Coverage too high?
Tatva Chintan Pharma Chem's current Interest Coverage of 10.44 is 13% below median its 10-year median of 12.01. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 23.17. The Chemicals industry median Interest Coverage is 10.26. Tatva Chintan Pharma Chem's value of 10.44 is 1.8% above this industry median. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #522 out of 1233 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Interest Coverage compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #522 out of 1233 companies for Interest Coverage. This puts Tatva Chintan Pharma Chem in the upper half of its industry. The industry median Interest Coverage is 10.26. Tatva Chintan Pharma Chem's value of 10.44 is 1.8% above this benchmark. Historically, Tatva Chintan Pharma Chem's own Interest Coverage has ranged from 5.08 to 23.17 over the past decade. While the company's 10-year median is 12.01 vs. the industry median of 10.26, Tatva Chintan Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Chemicals company?
The median Interest Coverage among Chemicals companies is 10.26, based on 1,233 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current Interest Coverage of 10.44 is 1.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tatva Chintan Pharma Chem and its competitors. For the Chemicals industry, the median Interest Coverage is 10.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current Interest Coverage is 10.44, which is 13% below median its own 10-year median of 12.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,491.99, compared to a current price of ₹1,428.45 — trading 4.3% below its estimated fair value. The current Interest Coverage is 10.44, which is 13% below median its 10-year median of 12.01 and 1.8% above the Chemicals industry median of 10.26. Tatva Chintan Pharma Chem's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current Interest Coverage is 10.44 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued.
The current stock price of ₹1,428.45 is trading 4.3% below its estimated GF Value™ of ₹1,491.99.
GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.
Key valuation signals for BOM:543321:
Interest Coverage: 10.44 (13% below median its 10-year median of 12.01)
GF Value™: ₹1,491.99 vs. price of ₹1,428.45 (4.3% below fair value)
Industry Position: 1.8% above the Chemicals median (#522 of 1233)
No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
79GF Score
Get the complete analysis for BOM:543321
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543321 has been successfully added to your 
